SAFETY AND EFFICACY OF SUBCUTANEOUS VERSUS INTRAVENOUS BORTEZOMIB IN PATIENTS WITH NEWLY ELDERLY DIAGNOSED MULTIPLE MYELOMA

被引：0
|
作者：
Bacchiarri, F. [1 ]
Nozzoli, C. [1 ]
Antonioli, E. [1 ]
Staderini, M. [1 ]
Barone, F. [1 ]
Guarrera, A. [1 ]
Messeri, M. [1 ]
Coltro, G. [1 ]
Grieco, P. [1 ]
Bosi, A. [1 ]
机构：
[1] Azienda Osped Univ Careggi, SODC Ematol, SOD Terapie Cellulari & Med Trasfus, Florence, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PU037
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF THREE SUBCUTANEOUS BORTEZOMIB COMBINATIONS IN ELDERLY, NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Cerrato, C.
    Oliva, S.
    Petrucci, M. T.
    Caraffa, P.
    Nozzoli, C.
    Finsinger, P.
    Larocca, A.
    De Rosa, L.
    De Paoli, L.
    Montefusco, V.
    Saraci, E.
    Villani, O.
    Carella, A. M.
    Benevolo, G.
    Morabito, F.
    Liberati, A. M.
    Derudas, D.
    Boccadoro, M.
    Sonneveld, P.
    Palumbo, A.
    HAEMATOLOGICA, 2014, 99 : 107 - 107
  • [2] COMPARATIVE EFFICACY OF SUBCUTANEOUS AND INTRAVENOUS ADMINISTRATION OF BORTEZOMIB IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Skvortsova, N.
    Pospelova, T.
    Kovynev, I.
    Nechunaeva, I.
    HAEMATOLOGICA, 2014, 99 : 657 - 657
  • [3] EFFICACY AND SAFETY OF WEEKLY INFUSION BORTEZOMIB IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Bringhen, S.
    Genuardi, M.
    Rossi, D.
    Petrucci, M.
    Andriani, A.
    Rizzi, R.
    Mele, G.
    Aitoro, G.
    Mettivier, V.
    Annibali, O.
    Rossini, F.
    Gentilini, P.
    Pavone, V.
    Cellini, C.
    Giuliani, N.
    Rauco, A.
    Baraldi, A.
    Dominietto, A.
    Capaldi, A.
    Pescosta, N.
    Rizzi, R.
    Nozza, A.
    Spadano, A.
    De Stefano, V.
    Holanek, M.
    Gaidano, G.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 149 - 149
  • [4] Subcutaneous Bortezomib, Melphalan and Prednisone in Elderly Newly Diagnosed Multiple Myeloma Patients
    Herbaux, Charles
    Joao, Cristina M.
    Plocque, Alexia
    Richez, Valentine
    Gay, Francesca
    Renaud, Loic
    Legros, Laurence
    Garderet, Laurent
    Ikhlef, Souhila
    Pegourie, Brigitte
    Escoffre-Barbe, Martine
    Royer, Bruno
    Voillat, Laurent
    Hulin, Cyrille
    Banos, Anne
    Voog, Eric G.
    Karlin, Lionel
    Stoppa, Anne-Marie
    Benboubker, Lotfi
    Zweegman, Sonja
    De Jongh, Eva
    Abildgaard, Niels
    Le Du, Katell
    Jurczyszyn, Artur J.
    Moreau, Philippe
    Facon, Thierry
    Caillot, Denis
    Terpos, Evangelos
    Leleu, Xavier
    BLOOD, 2014, 124 (21)
  • [5] Efficacy and safety of subcutaneous versus intravenous bortezomib in multiple myeloma: a meta-analysis
    Hu, Bin
    Zhou, Quan
    Wu, Tao
    Zhuang, Lan
    Yi, Liping
    Cao, Jinxia
    Yang, Xin
    Wang, Jun
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (04) : 329 - 338
  • [6] Safety and efficacy of subcutaneous formulation of bortezomib versus the conventional intravenous formulation in multiple myeloma
    Mateos, Maria-Victoria
    San Miguel, Jesus F.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (02) : 117 - 124
  • [7] Efficacy and safety of subcutaneous bortezomib versus intravenous bortezomib in patients with multiple myeloma: a systematic review and meta-analysis
    Zhang, Shilong
    Li, Jing
    Liu, Peng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (02): : 445 - +
  • [8] Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma
    Xu, Yan
    Deng, Shuhui
    Mao, Xuehan
    An, Gang
    Li, Zengjun
    Wang, Yafei
    Fulciniti, Mariateresa
    Ho, Matthew
    Lin, Jianhong
    Sui, Weiwei
    Liu, Wei
    Zou, Dehui
    Yi, Shuhua
    Huang, Wenyang
    Liu, Hong
    Lv, Rui
    Li, Jian
    Wang, Tingyu
    Du, Chenxing
    Munshi, Nikhil C.
    Qiu, Lugui
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (06): : 422 - 430
  • [9] Efficacy and safety of bortezomib maintenance in patients with newly diagnosed multiple myeloma: a meta-analysis
    Sun, Chun-yan
    Li, Jun-ying
    Chu, Zhang-bo
    Zhang, Lu
    Chen, Lei
    Hu, Yu
    BIOSCIENCE REPORTS, 2017, 37
  • [10] Clinical Risk Factors for Peripheral Neuropathy in Patients Treated with Subcutaneous or Intravenous Bortezomib for Newly Diagnosed Multiple Myeloma
    Merz, Maximillan
    Salwender, Hans-Juergen
    Haenel, Mathias
    Bertsch, Uta
    Kunz, Christina
    Hielscher, Thomas
    Blau, Igor W.
    Scheid, Christof
    Mai, Elias Karl
    Hose, Dirk
    Schurich, Baerbel
    Munder, Markus
    Brossart, Peter
    Gerecke, Christian
    Lindemann, Hans Walter
    Zeis, Matthias
    Weisel, Katja C.
    Duerig, Jan
    Goldschmidt, Hartmut
    BLOOD, 2015, 126 (23)
12345